Please login to the form below

Not currently logged in
Email:
Password:

Insulin prices

This page shows the latest Insulin prices news and features for those working in and with pharma, biotech and healthcare.

Novo Nordisk settles US insulin pricing dispute for $100m

Novo Nordisk settles US insulin pricing dispute for $100m

Novo Nordisk also faces political pressure in the US over the pricing of its insulin products. ... The letter noted that the companies raised their insulin prices at the same time and that the prices almost doubled between 2012 and 2016.

Latest news

  • Lilly joins new Medicare scheme to reduce insulin prices Lilly joins new Medicare scheme to reduce insulin prices

    Lilly has faced particularly strong criticism, after its widely-used Humalog insulin rose from $34 to $234 per vial between 2001 and 2015. ... excludes biologics such as insulin as well as intravenous drugs and controlled substances.

  • New drugs drive Novo Nordisk despite insulin price pressures New drugs drive Novo Nordisk despite insulin price pressures

    Although sales of its newer drugs have been growing, Novo has been facing challenges to its insulin franchise – in particular in the US, where prices of these products have been heavily ... Along with other insulin manufacturers, including Sanofi and

  • Novo bolstered by new diabetes, obesity products Novo bolstered by new diabetes, obesity products

    Sales of long-acting insulin also decreased by 2%, which was driven by declining Levemir sales. ... Insulin prices have been a hotly-debated topic as pharma companies face pricing pressure from patient groups and government officials, particularly in the

  • Democrats’ final pricing plan announced, 250 drugs targeted Democrats’ final pricing plan announced, 250 drugs targeted

    Pharma companies, under the proposed plan, would also have to offer agreed prices to private health insurance companies. ... Drug pricing in the US has been under scrutiny, with drugs prices, including insulin, increasing exponentially.

  • Novo follows Sanofi, Lilly with insulin price cut in US Novo follows Sanofi, Lilly with insulin price cut in US

    which offered a 50% cheaper version of its Humalog (insulin lispro) the following month. ... Those plans push list prices to patients to fulfil a deductible, which sometimes means paying thousands of dollars.”.

More from news
Approximately 3 fully matching, plus 10 partially matching documents found.

Latest Intelligence

  • The fight for affordable insulin The fight for affordable insulin

    Activists are organised, and demanding action on US insulin prices - and pointing the finger at pharma. ... prices. Reliance on US revenues. For the big three insulin companies, their reliance on US revenues runs deep.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
AMICULUM

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >300 healthcare communications professionals,...

Latest intelligence

Five big changes in the healthcare comms landscape
The world of healthcare has changed very greatly in the five years since The Difference Collective launched. Our agile model and talented team have enabled us to keep pace with...
Early communications in Pharma: How effective pre-approval comms delivers launch success
What communications are required for a successful launch...
Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....